Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells - Wikidata - awgldk - TriplyDB

Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells

Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells

http://www.wikidata.org/entity/Q24804892

about

Fusion of Hsp70 to Mage-a1 enhances the potency of vaccine-specific immune responses α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.A novel therapy for melanoma developed in mice: transformation of melanoma into dendritic cells with Listeria monocytogenes.Immunotherapy for melanoma: current status and perspectives.Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial.Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma.Ontogeny and phagocytic function of baboon lung dendritic cells.Advances in cellular therapy for the treatment of thyroid cancer.The biology of cancer testis antigens: putative function, regulation and therapeutic potential Recent progress in peptide vaccination in cancer with a focus on non-small-cell lung cancer.MAGE-A3: an immunogenic target used in clinical practice.Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay.Dendritic cell therapy in melanoma.Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.

P2860

Q33643966-3A3A96BF-743D-45C9-94B1-FC09235EB2B0 Q34523918-69FE4EE8-36BF-4A40-A734-A9FE391C207B Q35168418-AAA25F91-6F8F-4CD0-97EC-8CEF6CB0D22F Q36453216-2EF8116E-ED3B-44D0-9909-8C56CC156B72 Q36642308-E64FEE0E-40CD-4CAE-9E8B-4C735695A981 Q37086138-9D00F3E0-55A5-480C-AB10-883452CA3B84 Q37250195-0E7FCD3D-449E-4C12-A1FD-4E8F256E9C53 Q37776660-8B294303-15AE-409A-BE75-0415D96064CF Q37849976-C45CB3B2-4A67-49D5-BC72-FA79A1702A0A Q38168904-DD6D5AFF-DD5B-4099-9BDB-136DA1D548B3 Q38534721-7BE323EB-A270-4897-B1F1-5D6955489471 Q39329649-DC1241D8-04B1-403D-B8AC-ADCED0A361FB Q43923587-14FC3F75-7738-4CD6-BF9A-7DDB98438D25 Q53159624-24DFD3FC-9169-4011-A95B-383983CD289B

P2860

Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells

http://www.wikidata.org/entity/Q24804892

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Clinical response in Japanese ...... ocktail-pulsed dendritic cells

@ast

Clinical response in Japanese ...... ocktail-pulsed dendritic cells

@en

Clinical response in Japanese ...... ocktail-pulsed dendritic cells

@nl

type

label

Clinical response in Japanese ...... ocktail-pulsed dendritic cells

@ast

Clinical response in Japanese ...... ocktail-pulsed dendritic cells

@en

Clinical response in Japanese ...... ocktail-pulsed dendritic cells

@nl

prefLabel

Clinical response in Japanese ...... ocktail-pulsed dendritic cells

@ast

Clinical response in Japanese ...... ocktail-pulsed dendritic cells

@en

Clinical response in Japanese ...... ocktail-pulsed dendritic cells

@nl

P1433

Q24804892-C9F34ABD-34EC-4D8F-95EB-1F23AF9993D2

P1476

Q24804892-D83C5F7C-C2FB-4AB6-95AF-952326C057AC

P2093

Q24804892-32DFBA16-6B95-431C-B255-12E0E29CCA17

Q24804892-4EE86EAE-956E-4037-A29E-B46EFB8DB746

Q24804892-59B455C7-AF62-4C73-A69B-B02D2A671781

Q24804892-8023C410-F352-4903-8FE6-AB128E756051

Q24804892-81063865-2B4D-410F-9F23-9CDBD93B300E

Q24804892-A688142D-0630-4177-B654-87F719C0207C

Q24804892-B388E87D-FDD8-4B89-A7BB-687DD9ADF932

Q24804892-BBA15BFA-0F42-49BC-91C5-4EB67A6D27C0

Q24804892-BD99401A-ED76-4CCD-9E41-9BE7E6FAC89D

Q24804892-C1752A12-89E8-47EB-BA0A-255D3F8CAFCF

P2860

Q24804892-0943BE79-AFDB-4725-AB5B-F2F056CA123C

Q24804892-1F92F66F-7AE4-46FE-A678-5A4B2A0BCF9C

Q24804892-532C5DED-1313-41B5-A5AA-DBCB6A91A56E

Q24804892-5FF8DB44-CF6C-4E5D-A693-B14C552875C9

Q24804892-7F68F7C2-CAA7-4953-912B-6B0E55310D2E

Q24804892-81BC24F6-CD0F-495D-B538-610144B247ED

Q24804892-82848ED0-B1DE-4B95-97FE-9903367BC49A

Q24804892-948003B0-4361-42C6-9CFB-601990139443

Q24804892-9A97C2C6-BEEA-47C4-BC4B-28E689E98127

Q24804892-A041B157-28E4-4369-9687-C2E2BFCEA6D9

P2888

Q24804892-A4E2FAB9-4C5E-4BBA-B3B8-94990C846DB5

P304

Q24804892-2705AE36-6886-462A-9182-17ACF0AA402D

P31

Q24804892-086AE4F0-8BB1-4B32-9DA6-5BEF72EE5DD4

P356

Q24804892-719FA63B-44C5-469C-AACE-57466ED38670

P433

Q24804892-2CDC9269-0900-4E28-A247-84DB9B934627

P478

Q24804892-8098B379-9F0F-41B0-A7A5-ACCC0EBCA11B

P577

Q24804892-8DD64222-41C3-4BDA-9393-AA55FC716094

P5875

Q24804892-411A6BF5-979D-483C-9C1F-00779782760D

P6179

Q24804892-5E94D543-F11C-452B-BB07-07115C22F90D

P698

Q24804892-52B8FC8C-A8B4-446E-821A-4726F07F900A

P932

Q24804892-84FEC111-811C-4DEB-BC1D-63F7D28E473F

P356

P1433

Journal of Translational Medicine

P1476

Clinical response in Japanese ...... ocktail-pulsed dendritic cells

@en

P2093

Akifumi Yamamoto

http://www.w3.org/2001/XMLSchema#string

Ichiro Kawashima

http://www.w3.org/2001/XMLSchema#string

Ikuei Nukaya

http://www.w3.org/2001/XMLSchema#string

Kazutoh Takesako

http://www.w3.org/2001/XMLSchema#string

Ken Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Kouji Maruyama

http://www.w3.org/2001/XMLSchema#string

Makiko Shimada

http://www.w3.org/2001/XMLSchema#string

Naoki Inoue

http://www.w3.org/2001/XMLSchema#string

Naoya Yamazaki

http://www.w3.org/2001/XMLSchema#string

Ryuji Tanosaki

http://www.w3.org/2001/XMLSchema#string

P2860

Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules.

A listing of human tumor antigens recognized by T cells.

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression.

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes.

Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.

Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.

Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes.

Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.

P2888

P304

4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-3-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8056182

http://www.w3.org/2001/XMLSchema#string

P6179

1044352793

http://www.w3.org/2001/XMLSchema#string

P698

15676080

http://www.w3.org/2001/XMLSchema#string

P932

549033

http://www.w3.org/2001/XMLSchema#string